Publications by authors named "Xishuai Yang"

Article Synopsis
  • Rituximab (RTX) is a monoclonal antibody increasingly used to treat myasthenia gravis (MG), with studies investigating the effectiveness of low doses, although its benefits continue to be debated.* -
  • A systematic review and meta-analysis of 17 studies with 292 patients showed that 91% experienced improved clinical status after RTX treatment, and their Quantitative Myasthenia Gravis (QMG) scores significantly decreased.* -
  • In subgroups, 90% of patients with acetylcholine receptor antibody-positive MG and 97% of those with muscle-specific kinase antibody-positive MG reported clinical improvements, highlighting RTX's potential efficacy in treating different MG types.*
View Article and Find Full Text PDF

Aims: The study aims to evaluate the efficacy of low dose rituximab (RTX) in patients with muscle-specific kinase antibody positive myasthenia gravis (MuSK-MG).

Methods: This is a single-center, retrospective study. A total of 10 patients with MuSK-MG were admitted to the Department of Neurology, First Hospital, Shanxi Medical University, between April 2021 to April 2023.

View Article and Find Full Text PDF

Background: Currently, there is no consensus on the most appropriate technique for obtaining lateral hip radiographs after cephalomedullary nail (CMN) surgery. The aim of this study was to investigate the distribution of two commonly used postoperative lateral hip radiographic methods (classic lateral view and modified lateral view) and try to find out which one is better suited for this situation.

Methods: A retrospective analysis was conducted on 146 patients who underwent surgical fixation for extracapsular hip fractures between January 2018 and June 2022.

View Article and Find Full Text PDF

Background: CpG island methylator phenotype (CIMP) was closely related to the degree of pathological differentiation of tumors, and it's an important determinant of glioma pathogenicity. However, the molecular and pathological features of CIMP-positive glioma have not been fully elucidated. In addition, CIMP have been reported to be a useful prognostic marker in several human cancers, yet its prognostic value in gliomas is still controversial.

View Article and Find Full Text PDF